Answers are grounded in this paper and cite their sources.
Retrospective analysis reveals imaging biomarkers of idiopathic intracranial hypertension in patients, suggesting clinical significance.
Background: Idiopathic Intracranial Hypertension (IIH), or pseudotumor cerebri, is characterized by elevated intracranial pressure without a detectable secondary cause. The condition has an estimated incidence of 0.9 per 100,000 in the general population, rising to 19 per 100,000 among obese women of reproductive age. IIH is associated with significant morbidity, particularly vision loss, if not diagnosed and managed promptly. Methodology: This retrospective case series analyzed five patients evaluated between May 2024 and May 2025 who met the modified Dandy criteria for IIH and underwent standardized MRI and MRV protocols. Patient selection involved the exclusion of secondary intracranial hypertension, and two radiologists independently reviewed images. Results: All patients (100%) exhibited either partial or complete empty Sella, 80% (4/5) showed transverse sinus stenosis, 60% (3/5) had Meckel's cave enlargement; and 60% (3/5) had perioptic CSF space dilation; visual disturbances correlated with perioptic CSF distention. The study highlights the value of neuroimaging biomarkers in confirming IIH, guiding clinical management, and differentiating from secondary causes. However, the limited sample size and single-center scope restrict generalizability. Conclusion: Early radiological identification and intervention are crucial to prevent irreversible complications, emphasizing the need for multi-disciplinary care and further research involving advanced imaging and long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: